Item 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes to the risk factors as previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
We had two share repurchase authorizations outstanding during the quarter ended September 30, 2022. On May 4, 2022 and August 3, 2022, we publicly announced that our Board of Directors authorized the repurchase of our outstanding common stock in one or more open market and/or privately negotiated transactions, up to an aggregate of $500 million per authorization. The repurchase authorizations do not have expiration dates. We repurchased the following shares of our common stock during the third quarter of 2022:
| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in thousands) | ||||||||||||||||||||||
| July 1 - 31, 2022 | 9,430 | $ | 4,330.10 | 9,430 | $ | 451,507 | ||||||||||||||||||||
| August 1 - 31, 2022 | 29,460 | $ | 4,302.45 | 29,460 | $ | 824,757 | ||||||||||||||||||||
| September 1 - 30, 2022 | 49,126 | $ | 4,089.62 | 49,126 | $ | 623,850 | ||||||||||||||||||||
| Total | 88,016 | $ | 4,186.62 | 88,016 |
Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits